James McDonald
Internal Medicine · Kansas City, MONPI 1699733428
Payments from drug & device makers
Across 75 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$215
- AbbVie$203
- Revance Therapeutics, Inc.$176
- Novo Nordisk$104
- Astellas Pharma US Inc$97
- Abbott$72
- plus $458 from 19 others
What the payments were for
- Consulting fees$655%
- Food & beverage$1,25895%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$176
How this compares
$1,325 in reported general payments places this provider in the 75th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 69 | $81,974 |
| JardianceEmpagliflozin | 23 | $21,797 |
| FarxigaDapagliflozin Propanediol | 11 | $10,934 |
| Spiriva RespimatTiotropium Bromide | 12 | $10,907 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,762 |
| Fentanyl | 24 | $4,509 |
| Naloxone Hcl | 18 | $1,264 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $978 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $871 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $865 |
| Modafinil | 18 | $616 |
| Gabapentin | 44 | $582 |
| Potassium Chloride | 29 | $547 |
| Levothyroxine Sodium | 57 | $528 |
| Bupropion XlBupropion Hcl | 21 | $525 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $24 | $81,97469 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $70 | $32,70435 claims |
| AstraZenecaFarxiga | $11 | $10,93411 claims |
| GSKTrelegy Ellipta | $26 | $7,76212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Kansas City
- Craig DietzKansas City$4M
- Santosh SharmaKansas City$782K
- Kevin SuttmoellerKansas City$198K
- Karla Houston-GrayKansas City$24K
- Timothy SmithSaint Peters$21.4M
- Michael ReschakSaint Louis$3.1M
- Dima DandachiColumbia$1.2M
- Jianbo WangChesterfield$643K
- David PrelutskySaint Louis$575K
- Danish JabbarSaint Louis$510K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.